Treeline Biosciences is a developer of groundbreaking precision medicines designed to combat cancer and other critical conditions. The company's platform leverages insights into normal and disease pathophysiology, experimental data, genomics, and pattern recognition to create transformative precision solutions for unmet patient needs. This approach empowers medical professionals to effectively treat cancer and other severe health issues.

Investors Include:

Casdin Capital, OrbiMed, Aisling Capital, Kohlberg Kravis Roberts, ARCH Venture Partners, Zeus Health, GV, Access Industries, Ajax Health, Rock Springs Capital, T. Rowe Price Group.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Our available services for this company

Lifetime IncomeCharitable Remainder Trust

Tax SavingsDonor Advised Fund